|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/24 | |
| C12N 1/20 | |||
| C12N 15/00 | |||
| C07H 21/04 | |||
| A61K 38/47 | |||
| A61K 38/00 | |||
| A61K 39/00 |
| (11) | Number of the document | 3241898 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17164276.2 |
| Date of filing the European patent application | 2005-07-21 | |
| (97) | Date of publication of the European application | 2017-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 939262 | 2004-09-10 | US |
| (72) |
FANG, Fang, US
MALAKHOV, Michael, US
|
| (73) |
Ansun Biopharma, Inc.,
3030 Callan Road, San Diego, CA 92121,
US
|
| (54) | A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |
| A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |